Neuronetics, Inc.

Healthcare

NASDAQ:STIM · NASDAQ Global Market

Market Cap $85.59M Beta 1.04 P/E (TTM) -2.3

$1.23 +0.31%

+$0.00 today

52W Low $0.80High $4.85

Vol 1.61M · Avg 2.44M

EPS (TTM) -$0.53Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-64.14%

Period High

$4.66

Period Low

$1.18

Latest

$1.23

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Genfit S.A.

GNFT

$445.68M

Prenetics Global Limited

NASDAQ:PRE

$341.71M

OraSure Technologies, Inc.

NASDAQ:OSUR

$299.84M

OmniAb, Inc.

NASDAQ:OABI

$260.21M

Perspective Therapeutics, Inc.

AMEX:CATX

$235.61M

Codexis, Inc.

NASDAQ:CDXS

$226.79M

Profound Medical Corp.

NASDAQ:PROF

$205.16M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$71.88M

Nyxoah S.A.

NASDAQ:NYXH

$62.98M

Atlantic International Corp.

NASDAQ:ATLN

$42.50M

What is the latest STIM filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does STIM have?

Intrinsic Alpha currently shows 20 recent filings for STIM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.